ScoreComparison
Why is AnaptysBio, Inc. ?
1
With a growth in Net Profit of 228.29%, the company declared Very Positive results in Sep 25
- The company has declared positive results for the last 3 consecutive quarters
- RAW MATERIAL COST(Y) Fallen by -1.23% (YoY)
- DEBT-EQUITY RATIO (HY) Lowest at -331.43 %
- NET SALES(Q) Highest at USD 76.32 MM
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 267.21%, its profits have risen by 46.5%
3
Reducing Promoter Confidence
- Promoters have decreased their stake in the company by -1.46% over the previous quarter and currently hold 10.98% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
4
Market Beating performance in long term as well as near term
- Along with generating 267.21% returns in the last 1 year, the stock has outperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to AnaptysBio, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is AnaptysBio, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
AnaptysBio, Inc.
267.21%
2.53
65.39%
S&P 500
16.12%
0.84
19.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
56.59%
EBIT Growth (5y)
10.39%
EBIT to Interest (avg)
-10.25
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
0.19
Tax Ratio
0.03%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-63.31
EV to EBIT
-67.91
EV to EBITDA
-74.16
EV to Capital Employed
35.08
EV to Sales
11.49
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-51.66%
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend33What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -1.23% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -331.43 %
NET SALES(Q)
Highest at USD 76.32 MM
OPERATING PROFIT(Q)
Highest at USD 35.31 MM
OPERATING PROFIT MARGIN(Q)
Highest at 46.27 %
PRE-TAX PROFIT(Q)
Highest at USD 15.11 MM
NET PROFIT(Q)
Highest at USD 15.11 MM
EPS(Q)
Highest at USD 0.52
-14What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -145.08 MM
CASH AND EQV(HY)
Lowest at USD 514.67 MM
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.86 times
INTEREST(Q)
Highest at USD 22.52 MM
Here's what is working for AnaptysBio, Inc.
Net Sales
At USD 76.32 MM has Grown at 147.86%
over average net sales of the previous four periods of USD 30.79 MMMOJO Watch
Near term sales trend is extremely positive
Net Sales (USD MM)
Pre-Tax Profit
At USD 15.11 MM has Grown at 145.62%
over average net sales of the previous four periods of USD -33.13 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 15.11 MM has Grown at 145.59%
over average net sales of the previous four periods of USD -33.15 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Net Sales
Highest at USD 76.32 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD 35.31 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 46.27 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD 15.11 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 15.11 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 0.52
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Debt-Equity Ratio
Lowest at -331.43 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -1.23% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for AnaptysBio, Inc.
Operating Cash Flow
Lowest at USD -145.08 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Interest
At USD 22.52 MM has Grown at 14.84%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Interest
Highest at USD 22.52 MM
in the last five periods and Increased by 14.84% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Cash and Eqv
Lowest at USD 514.67 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debtors Turnover Ratio
Lowest at 3.86 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Non Operating Income
Highest at USD 0.19 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
